Time to stop progesterone receptor testing in breast cancer management

被引：76
作者：
Olivotto, IA [1 ]
Truong, PT
Speers, CH
Bernstein, V
Allan, SJ
Kelly, SJ
Lesperance, ML
机构：
[1] British Columbia Canc Agcy, Vancouver Isl Ctr, Radiat Therapy Program, Breast Canc Outcomes Unit, Victoria, BC, Canada
[2] British Columbia Canc Agcy, Vancouver Isl Ctr, Syst Therapy Program, Victoria, BC, Canada
[3] Vancouver Isl Hlth Author, Dept Pathol, Victoria, BC, Canada
[4] Univ Victoria, Dept Math & Stat, Victoria, BC V8W 2Y2, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 09期
关键词：
D O I：
10.1200/JCO.2004.99.251
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1769 / 1770
页数：2
相关论文
共 6 条
  • [1] Bast RC, 1996, J CLIN ONCOL, V14, P2843
  • [2] *EARL BREAST CANC, 1992, LANCET, V339, P1
  • [3] RELATIVE WORTH OF ESTROGEN OR PROGESTERONE-RECEPTOR AND PATHOLOGIC CHARACTERISTICS OF DIFFERENTIATION AS INDICATORS OF PROGNOSIS IN NODE NEGATIVE BREAST-CANCER PATIENTS - FINDINGS FROM NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT PROTOCOL B-06
    FISHER, B
    REDMOND, C
    FISHER, ER
    CAPLAN, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (07) : 1076 - 1087
  • [4] Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer
    Harvey, JM
    Clark, GM
    Osborne, CK
    Allred, DC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) : 1474 - 1481
  • [5] PROGNOSTIC-SIGNIFICANCE OF ESTROGEN AND PROGESTOGEN RECEPTOR ACTIVITIES IN BREAST-CANCER
    HAWKINS, RA
    WHITE, G
    BUNDRED, NJ
    DIXON, JMJ
    MILLER, WR
    STEWART, HJ
    FORREST, APM
    [J]. BRITISH JOURNAL OF SURGERY, 1987, 74 (11) : 1009 - 1013
  • [6] Oestrogen and progesterone receptors as prognostic variables in hormonally treated breast cancer
    Robertson, JFR
    Cannon, PM
    Nicholson, RI
    Blamey, RW
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1996, 11 (01) : 29 - 35
1